These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Progress in direct reprogramming of dopaminergic cell replacement therapy. Zheng YY; Xu H; Wang YS Neurol Sci; 2024 Mar; 45(3):873-881. PubMed ID: 37945931 [TBL] [Abstract][Full Text] [Related]
4. Open Science Meets Stem Cells: A New Drug Discovery Approach for Neurodegenerative Disorders. Han C; Chaineau M; Chen CX; Beitel LK; Durcan TM Front Neurosci; 2018; 12():47. PubMed ID: 29467610 [TBL] [Abstract][Full Text] [Related]
9. Induction of Oxidative Stress in SH-SY5Y Cells by Overexpression of hTau40 and Its Mitigation by Redox-Active Nanoparticles. Pieńkowska N; Fahnestock M; Mahadeo C; Zaborniak I; Chmielarz P; Bartosz G; Sadowska-Bartosz I Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613801 [TBL] [Abstract][Full Text] [Related]
10. Integrative Analyses of Transcriptomes to Explore Common Molecular Effects of Antipsychotic Drugs. Truong TTT; Bortolasci CC; Kidnapillai S; Spolding B; Panizzutti B; Liu ZSJ; Kim JH; Dean OM; Richardson MF; Berk M; Walder K Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886854 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's Disease: Overview of Transcription Factor Regulation, Genetics, and Cellular and Animal Models. Xia N; Cabin DE; Fang F; Reijo Pera RA Front Neurosci; 2022; 16():894620. PubMed ID: 35600613 [TBL] [Abstract][Full Text] [Related]
12. Embryoid Body Formation from Mouse and Human Pluripotent Stem Cells for Transplantation to Study Brain Microenvironment and Cellular Differentiation. Guerra-Crespo M; Collazo-Navarrete O; Ramos-Acevedo R; Morato-Torres CA; Schüle B Methods Mol Biol; 2022; 2520():215-232. PubMed ID: 34611820 [TBL] [Abstract][Full Text] [Related]
13. Development of a physiologically relevant and easily scalable LUHMES cell-based model of G2019S LRRK2-driven Parkinson's disease. Calamini B; Geyer N; Huss-Braun N; Bernhardt A; Harsany V; Rival P; Cindhuchao M; Hoffmann D; Gratzer S Dis Model Mech; 2021 Jun; 14(6):. PubMed ID: 34114604 [TBL] [Abstract][Full Text] [Related]
14. A compendious summary of Parkinson's disease patient-derived iPSCs in the first decade. Ren C; Wang F; Guan LN; Cheng XY; Zhang CY; Geng DQ; Liu CF Ann Transl Med; 2019 Nov; 7(22):685. PubMed ID: 31930086 [TBL] [Abstract][Full Text] [Related]
16. The neuroprotective effect of BSA-based nanocurcumin against 6-OHDA-induced cell death in SH-SY5Y cells. Sookhaklari R; Geramizadeh B; Abkar M; Moosavi M Avicenna J Phytomed; 2019; 9(2):92-100. PubMed ID: 30984574 [TBL] [Abstract][Full Text] [Related]
17. Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases. Kumar S; Karthikeyan N; Mishra S; Padmanabhan P; Radda G; Gulyás B Mol Neurobiol; 2019 Apr; 56(4):2559-2578. PubMed ID: 30043261 [TBL] [Abstract][Full Text] [Related]
18. Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease. Piper DA; Sastre D; Schüle B Front Neurosci; 2018; 12():199. PubMed ID: 29686602 [TBL] [Abstract][Full Text] [Related]
19. iPS cells in the study of PD molecular pathogenesis. Cobb MM; Ravisankar A; Skibinski G; Finkbeiner S Cell Tissue Res; 2018 Jul; 373(1):61-77. PubMed ID: 29234887 [TBL] [Abstract][Full Text] [Related]
20. Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models. Lopes FM; Bristot IJ; da Motta LL; Parsons RB; Klamt F Neuromolecular Med; 2017 Sep; 19(2-3):241-255. PubMed ID: 28721669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]